MIR

Mirion Technologies, Inc. · NYSE

News

3 latest

Zacks Investment Research

Does Mirion Technologies (MIR) Have the Potential to Rally 47.97% as Wall Street Analysts Expect?

Mirion Technologies (MIR) closed at $16.22 with a mean analyst price target of $24, suggesting 48% upside potential. The stock has a Zacks Rank #2 (Buy) rating and shows positive earnings estimate revisions over the last 30 days. However, the article cautions that price targets alone should not be the sole basis for investment decisions, as analysts often set overly optimistic targets due to business incentives.

Zacks Investment Research

Mirion Technologies (MIR) Upgraded to Buy: Here's What You Should Know

Mirion Technologies has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting rising earnings estimates over the past three months. The upgrade positions the company in the top 20% of Zacks-covered stocks, suggesting potential near-term stock price appreciation driven by improving business fundamentals and institutional investor interest.

Mentions MIR

Zacks Investment Research

Analysts Estimate Aurora Innovation, Inc. (AUR) to Report a Decline in Earnings: What to Look Out for

Aurora Innovation (AUR) is expected to report a year-over-year earnings decline despite higher revenues when it releases Q3 2026 results on October 28. The company is projected to post a quarterly loss of $0.12 per share (down 9.1% YoY) with revenues of $3.23 million (up 223% YoY). Consensus EPS estimates have been revised 2.86% lower over the last 30 days, indicating analyst caution about the company's near-term earnings prospects.

Headlines link to the publisher. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.